Doug Loe Archives - BioTuesdays

Markets

Leede Jones Gable cuts Medical Facilities to hold on EBITDA margins

Leede Jones Gable downgraded Medical Facilities (TSX:DR) to “hold” from “buy” and lowered its price target to $9.25 (Canadian) from $12, citing solid top-line data in the third quarter of 2022, offset by cost pressures...

November 11, 2022

Markets

Leede Jones Gable starts ProMIS at speculative buy; PT 50 cents (Canadian)

Leede Jones Gable initiated coverage of ProMIS Neurosciences (TSX:PMN) with a “speculative buy” rating and price target of 50 cents (Canadian). The stock closed at 11 cents on May 10. The firm’s lead preclinical...

May 11, 2022

Markets

Leede Jones Gable starts Perimeter Medical Imaging at speculative buy; PT $6.75 (Canadian)

Leede Jones Gable initiated coverage of Perimeter Medical Imaging (TSXV:PINK) with a “speculative buy” rating and price target of $6.75 (Canadian). The stock closed at $4.30 on March 26. The firm’s lead medical device...

March 29, 2021

Markets

Leede Jones Gable starts Cardiol Therapeutics at speculative buy; PT $12.50 (Canadian)

Leede Jones Gable initiated coverage of Cardiol Therapeutics (TSX:CRDL) with a “speculative buy” rating and price target of $12.50 (Canadian). The stock closed at $4.51 on March 24. Analyst Doug Loe, Ph.D., writes that...

March 25, 2021

Markets

Leede Jones Gable starts Profound Medical at buy; PT $36.50 (Canadian)

Leede Jones Gable launched coverage of Profound Medical (TSX:PRN) with a “buy” rating and price target of $36.50 (Canadian). The stock gained $2.96, or 13%, to close at $26.18 on Dec. 21. The firm’s flagship device...

December 22, 2020

Markets

Leede Jones Gable starts Protech Home Medical at buy; PT $3.25

Leede Jones Gable initiated coverage of Protech Home Medical (TSXV:PTQ) with a “buy” rating and price target of $3.25. The stock closed at $1.47 on Dec. 18. Protech is a durable medical equipment (DME) and home...

December 21, 2020

Markets

Leede Jones Gable starts IntelGenx at speculative buy; PT $1 (Canadian)

Leede Jones Gable initiated coverage of IntelGenx Technologies (TSXV:IGX) with a “speculative buy” rating and price target of $1.00 (Canadian). The stock closed at 37 cents on Dec. 15. IntelGenx is a thin-film...

December 16, 2020

Markets

Leede Jones Gable starts IMV at speculative buy; PT $10.50 (Canadian)

Leede Jones Gable launched coverage of IMV (TSX:IMV) with a “speculative buy” and price target of $10.50 (Canadian). The stock closed at $4.03 on Dec. 15. IMV’s flagship technology platform is the lipid-based water-free...

December 16, 2020

Markets

Leede Jones Gable starts Liminal BioSciences at hold; PT $4

Leede Jones Gable initiated coverage of Liminal BioSciences (NASDAQ:LMNL) with a “hold” rating and $4 price target. The stock closed at $4.20 on Dec. 15. Liminal is a plasma products and anti-fibrotic small molecule...

December 16, 2020

Markets

Leede Jones Gable starts Oncolytics Biotech at speculative buy; PT $8.50 (Canadian)

Leede Jones Gable launched coverage of Oncolytics Biotech (TSX:ONC) with a “speculative buy” rating and $8.50 (Canadian) price target. The stock closed at $3.07 on Dec. 15. Oncolytics is a cancer-focused virus-based...

December 16, 2020

Tag - Doug Loe

Leede Jones Gable cuts Medical Facilities to hold on EBITDA margins

Leede Jones Gable starts ProMIS at speculative buy; PT 50 cents (Canadian)

Leede Jones Gable starts Perimeter Medical Imaging at speculative buy; PT $6.75 (Canadian)

Leede Jones Gable starts Cardiol Therapeutics at speculative buy; PT $12.50 (Canadian)

Leede Jones Gable starts Profound Medical at buy; PT $36.50 (Canadian)

Leede Jones Gable starts Protech Home Medical at buy; PT $3.25

Leede Jones Gable starts IntelGenx at speculative buy; PT $1 (Canadian)

Leede Jones Gable starts IMV at speculative buy; PT $10.50 (Canadian)

Leede Jones Gable starts Liminal BioSciences at hold; PT $4

Leede Jones Gable starts Oncolytics Biotech at speculative buy; PT $8.50 (Canadian)

General

More